Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2010 1
2011 1
2018 1
2019 1
2020 2
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Virtual Multiple Mini-Interview during the COVID-19 Pandemic.
Ungtrakul T, Lamlertthon W, Boonchoo B, Auewarakul C. Ungtrakul T, et al. Among authors: lamlertthon w. Med Educ. 2020 Aug;54(8):764-765. doi: 10.1111/medu.14207. Epub 2020 Jun 26. Med Educ. 2020. PMID: 32365236 No abstract available.
Immunogenicity evaluation of ChAdox1 nCov-19 (AZD1222) vaccine in solid cancer patients in Chulabhorn Hospital.
Limpawittayakul P, Sungkasubun P, Chaiwiriyawong W, Supavavej A, Weerasubpong B, Siripaibun J, Phanthunane C, Lamlertthon W, Ungtrakul T, Tawinprai K, Tantiyavarong W, Samdaengpan C. Limpawittayakul P, et al. Among authors: lamlertthon w. Hum Vaccin Immunother. 2022 Nov 30;18(6):2104058. doi: 10.1080/21645515.2022.2104058. Epub 2022 Aug 17. Hum Vaccin Immunother. 2022. PMID: 35976687 Free PMC article.
Songkran: A novel medical school module for Thailand.
Rashid A, Auewarakul C, Lamlertthon W, Griffin A. Rashid A, et al. Among authors: lamlertthon w. Med Educ. 2020 May;54(5):440. doi: 10.1111/medu.14092. Epub 2020 Mar 22. Med Educ. 2020. PMID: 32201967 No abstract available.
Difference in Immunogenic Responses to COVID-19 Vaccines in Patients With Cancer Receiving Chemotherapy Versus Nonchemotherapy Treatment.
Tantiyavarong W, Sungkasubun P, Chaiwiriyawong W, Supavavej A, Limpawittayakul P, Weerasubpong B, Siripaibun J, Phanthunane C, Lamlertthon W, Ungtrakul T, Tawinprai K, Tantiyavarong P, Samdaengpan C. Tantiyavarong W, et al. Among authors: lamlertthon w. JCO Glob Oncol. 2023 Feb;9:e2200331. doi: 10.1200/GO.22.00331. JCO Glob Oncol. 2023. PMID: 36821802 Free PMC article.
Phase II Studies with Refametinib or Refametinib plus Sorafenib in Patients with RAS-Mutated Hepatocellular Carcinoma.
Lim HY, Merle P, Weiss KH, Yau T, Ross P, Mazzaferro V, Blanc JF, Ma YT, Yen CJ, Kocsis J, Choo SP, Sukeepaisarnjaroen W, Gérolami R, Dufour JF, Gane EJ, Ryoo BY, Peck-Radosavljevic M, Dao T, Yeo W, Lamlertthon W, Thongsawat S, Teufel M, Roth K, Reis D, Childs BH, Krissel H, Llovet JM. Lim HY, et al. Among authors: lamlertthon w. Clin Cancer Res. 2018 Oct 1;24(19):4650-4661. doi: 10.1158/1078-0432.CCR-17-3588. Epub 2018 Jun 27. Clin Cancer Res. 2018. PMID: 29950351 Free article. Clinical Trial.
Genetic Aberration Analysis in Thai Colorectal Adenoma and Early-Stage Adenocarcinoma Patients by Whole-Exome Sequencing.
Intarajak T, Udomchaiprasertkul W, Bunyoo C, Yimnoon J, Soonklang K, Wiriyaukaradecha K, Lamlertthon W, Sricharunrat T, Chaiwiriyawong W, Siriphongpreeda B, Sutheeworapong S, Kusonmano K, Kittichotirat W, Thammarongtham C, Jenjaroenpun P, Wongsurawat T, Nookaew I, Auewarakul C, Cheevadhanarak S. Intarajak T, et al. Among authors: lamlertthon w. Cancers (Basel). 2019 Jul 12;11(7):977. doi: 10.3390/cancers11070977. Cancers (Basel). 2019. PMID: 31336886 Free PMC article.
Age- and sex-specific genomic profiles in non-small cell lung cancer.
Mostertz W, Stevenson M, Acharya C, Chan I, Walters K, Lamlertthon W, Barry W, Crawford J, Nevins J, Potti A. Mostertz W, et al. Among authors: lamlertthon w. JAMA. 2010 Feb 10;303(6):535-43. doi: 10.1001/jama.2010.80. JAMA. 2010. PMID: 20145230